White label – Pompe disease - ClinicalTrials.eu

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
+2
Study of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan

Recruiting

2 1

+1
Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Recruiting

2 1

+2
Study of fampridine treatment for patients with spinocerebellar ataxia SCA27B caused by FGF14 gene mutation

Recruiting

3 1 1
Investigated Diseases:
- Hereditary ataxia
Investigated Drugs:
- Fampridine
Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

Recruiting

2 1
Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

Recruiting

2 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
- Tirzepatide
Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

Recruiting

3 1 1 1
Investigated Diseases:
- Acarodermatitis
Investigated Drugs:
- Ivermectin
Study of melphalan followed by trifluridine-tipiracil and bevacizumab combination versus trifluridine-tipiracil and bevacizumab in liver metastatic colorectal cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer
- Colorectal cancer metastatic
Investigated Drugs:
Study of NVG-2089 given by intravenous infusion in patients with immune thrombocytopenia to evaluate safety and effectiveness

Recruiting

2 1 1 1
Investigated Diseases:
- Immune thrombocytopenia
Investigated Drugs:
- NVG-2089
- Human Normal Immunoglobulin (Iv)
Study of ziltivekimab compared to placebo in patients with acute heart attack to evaluate its effects on coronary artery plaque reduction

Recruiting

3 1
Investigated Drugs:
- Ziltivekimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies